ScoreCardiology

Bleeding risk in atrial fibrillation (ATRIA)

Estimates the annual risk of major haemorrhage in patients with atrial fibrillation on warfarin.

Updated 31 October 2026

When to use it

Non-valvular atrial fibrillation when oral anticoagulation is considered or used, to identify bleeding risk factors.

What it needs

  • Anaemia (Hb < 13 g/dL men, < 12 g/dL women)Yes or no
  • Severe renal disease (eGFR < 30 mL/min or dialysis)Yes or no
  • Age ≥ 75 yearsYes or no
  • Prior haemorrhageYes or no
  • Diagnosed hypertensionYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

ATRIA score
ResultInterpretation
≤ 3Low risk (0–3): ≈ 0.8 % major bleeds/year
4Intermediate risk (4): ≈ 2.6 %/year
≥ 5High risk (5–10): ≈ 5.8 %/year

Practical tip

Derived in warfarin-treated patients (ATRIA cohort); its performance with direct oral anticoagulants is less studied.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top